loading
Precedente Chiudi:
$1.65
Aprire:
$1.62
Volume 24 ore:
51,347
Relative Volume:
0.47
Capitalizzazione di mercato:
$91.96M
Reddito:
-
Utile/perdita netta:
$-21.38M
Rapporto P/E:
-4.2823
EPS:
-0.39
Flusso di cassa netto:
$-25.19M
1 W Prestazione:
+8.45%
1M Prestazione:
+12.09%
6M Prestazione:
+102.41%
1 anno Prestazione:
+39.17%
Intervallo 1D:
Value
$1.62
$1.732
Intervallo di 1 settimana:
Value
$1.46
$1.74
Portata 52W:
Value
$0.51
$2.86

Connect Biopharma Holdings Ltd Stock (CNTB) Company Profile

Name
Nome
Connect Biopharma Holdings Ltd
Name
Telefono
858-727-1040
Name
Indirizzo
3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO
Name
Dipendente
62
Name
Cinguettio
Name
Prossima data di guadagno
2024-04-16
Name
Ultimi documenti SEC
Name
CNTB's Discussions on Twitter

Confronta CNTB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CNTB
Connect Biopharma Holdings Ltd
1.665 91.96M 0 -21.38M -25.19M -0.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.31 109.22B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
631.59 67.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
424.57 57.35B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
838.91 50.87B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
183.55 39.72B 447.02M -1.18B -868.57M -6.1812

Connect Biopharma Holdings Ltd Stock (CNTB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-10-31 Iniziato BTIG Research Buy
2025-06-12 Iniziato H.C. Wainwright Buy
2024-03-04 Iniziato H.C. Wainwright Buy
2021-04-13 Iniziato Jefferies Buy
2021-04-13 Iniziato Piper Sandler Overweight
2021-04-13 Iniziato SVB Leerink Outperform
Mostra tutto

Connect Biopharma Holdings Ltd Borsa (CNTB) Ultime notizie

pulisher
Nov 03, 2025

Join Connect Biopharma's Exclusive Live Investor Webinar and Q&A Session on November 3 - Bucyrus Telegraph-Forum

Nov 03, 2025
pulisher
Oct 31, 2025

This Immuneering Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga

Oct 31, 2025
pulisher
Oct 31, 2025

Connect Biopharma stock initiated with Buy rating at BTIG on respiratory drug potential - Investing.com Nigeria

Oct 31, 2025
pulisher
Oct 31, 2025

BTIG Initiates Coverage on Connect Biopharma Hldgs (CNTB) with 'Buy' Rating | CNTB Stock News - GuruFocus

Oct 31, 2025
pulisher
Oct 29, 2025

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Short Interest Update - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Connect Biopharma (NASDAQ:CNTB) Stock Price Down 3.8%What's Next? - MarketBeat

Oct 29, 2025
pulisher
Oct 27, 2025

All In Solutions Detox Enhances California Center Recovery Environment Through Tranquil Setting - The News Journal

Oct 27, 2025
pulisher
Oct 27, 2025

RestoPros of Southwest Florida Expands Damage Restoration Services Across Multiple Counties - azcentral.com and The Arizona Republic

Oct 27, 2025
pulisher
Oct 25, 2025

Connect Biopharma's (CNTB) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat

Oct 25, 2025
pulisher
Oct 19, 2025

Hyperke Growth Partners Reveals How They Help SEO Agencies with Qualified Lead Generation in Case Study - azcentral.com and The Arizona Republic

Oct 19, 2025
pulisher
Oct 10, 2025

Connect Biopharma's (CNTB) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 08, 2025

Severe Asthma Pipeline 2025: Therapies Under Investigation, - openPR.com

Oct 08, 2025
pulisher
Oct 07, 2025

Connect Biopharma (NASDAQ:CNTB) Stock Price Up 7.4%Still a Buy? - MarketBeat

Oct 07, 2025
pulisher
Oct 07, 2025

Connect Biopharma Holdings Limited (CNTB) stock price, news, quote and history - Yahoo

Oct 07, 2025
pulisher
Oct 06, 2025

October 2025's Promising Penny Stocks To Consider - Yahoo Finance

Oct 06, 2025
pulisher
Oct 03, 2025

Short Interest in Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Drops By 53.6% - MarketBeat

Oct 03, 2025
pulisher
Sep 30, 2025

H.C. Wainwright reiterates Buy rating on Connect Biopharma stock at $7 target By Investing.com - Investing.com South Africa

Sep 30, 2025
pulisher
Sep 30, 2025

H.C. Wainwright reiterates Buy rating on Connect Biopharma stock at $7 target - Investing.com Nigeria

Sep 30, 2025
pulisher
Sep 29, 2025

507mL Lung Function Improvement: Connect Bio's New Asthma Drug Shows Remarkable Results in High-Risk Patients - Stock Titan

Sep 29, 2025
pulisher
Sep 26, 2025

James Huang to join CASI Pharmaceuticals board as independent director By Investing.com - Investing.com Australia

Sep 26, 2025
pulisher
Sep 26, 2025

CASI Pharmaceuticals Appoints James Huang to Board of Directors - ACCESS Newswire

Sep 26, 2025
pulisher
Sep 26, 2025

35-Year Biotech Veteran James Huang Joins CASI Pharma Board as Company Advances CID-103 Program - Stock Titan

Sep 26, 2025
pulisher
Sep 22, 2025

Eosinophilic Asthma Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Lanier Biotherapeutics, Bio-Thera Solutions, Kinaset Therapeutics, CSPC ZhongQi Pharma - Barchart.com

Sep 22, 2025
pulisher
Sep 22, 2025

Eosinophilic Asthma Pipeline 2025: Therapies, MOA Insights, - openPR.com

Sep 22, 2025
pulisher
Sep 20, 2025

FY2025 EPS Estimate for Connect Biopharma Lowered by Analyst - MarketBeat

Sep 20, 2025
pulisher
Sep 18, 2025

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Sees Large Drop in Short Interest - MarketBeat

Sep 18, 2025
pulisher
Sep 09, 2025

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Short Interest Up 204.8% in August - MarketBeat

Sep 09, 2025
pulisher
Sep 08, 2025

Asthma Market to Show Paltry Growth at a CAGR of 1.95% During the Forecast Period (2025-2034) | DelveInsight - Yahoo Finance

Sep 08, 2025
pulisher
Sep 06, 2025

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Sees Large Increase in Short Interest - Defense World

Sep 06, 2025
pulisher
Sep 04, 2025

Connect Biopharma Announces Poster Presentations of Rademikibart at the European Respiratory Society Congress 2025 - Quiver Quantitative

Sep 04, 2025
pulisher
Sep 04, 2025

New Asthma Treatment Data: Connect Biopharma's Rademikibart Shows Impact on FEV1 in Type 2 Asthma Trial - Stock Titan

Sep 04, 2025
pulisher
Sep 03, 2025

Connect Biopharma completes termination of its American depositary receipt program and directly lists its ordinary shares on Nasdaq - MarketScreener

Sep 03, 2025
pulisher
Sep 03, 2025

Connect Biopharma Ends ADR Program, Moves to Direct Nasdaq Listing; Shares Up Premarket - MarketScreener

Sep 03, 2025
pulisher
Sep 03, 2025

Connect Biopharma Completes Termination of its American - GlobeNewswire

Sep 03, 2025
pulisher
Sep 03, 2025

Biotech Connect Biopharma Completes Strategic Shift to Direct Nasdaq Listing for U.S. Growth - Stock Titan

Sep 03, 2025
pulisher
Sep 02, 2025

COPD Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Genentech, GlaxoSmithKline, Verona Pharma, Regeneron Pharma, Sanofi, MedImmune, EpiEndo Pharma, Tetherex Pharma - Barchart.com

Sep 02, 2025
pulisher
Sep 02, 2025

3 Penny Stocks To Watch With Market Caps Over $100M - simplywall.st

Sep 02, 2025
pulisher
Aug 29, 2025

Connect Biopharma (CNTB) Expected to Announce Quarterly Earnings on Friday - Defense World

Aug 29, 2025
pulisher
Aug 27, 2025

Connect Biopharma Holdings Limited to Participate in Upcoming Healthcare Conferences - Quiver Quantitative

Aug 27, 2025
pulisher
Aug 27, 2025

Clinical-Stage Biotech Connect Biopharma Announces Key September Investor Conference Appearances - Stock Titan

Aug 27, 2025

Connect Biopharma Holdings Ltd Azioni (CNTB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$37.66
price up icon 1.02%
$29.02
price up icon 1.08%
$101.78
price up icon 0.22%
$103.02
price down icon 0.86%
biotechnology ONC
$312.10
price up icon 0.00%
$183.68
price down icon 1.32%
Capitalizzazione:     |  Volume (24 ore):